Moody’s assigned a provisional Ba2 rating to New Hampshire’s bond project, placing it below investment grade, as it cited Bitcoin’s volatility.
Latest NewsRead More
You might also be interested in reading The Oncology Institute anticipates Q4 adjusted EBITDA positivity as pharmacy revenue grows 41%.